![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Cambrex Threatened with Delisting from NYSE7:19 AM MDT | April 15, 2009 | Alex Scott Cambrex, one of the best known U.S. contract fine chemical manufacturers, has disclosed that it has received notification from the New York Stock Exchange (NYSE) that its listing on the exchange is under threat because its market capitalization has dipped below $75 million. NYSE rules stipulate that listed companies must have a market capitalization of more than $75 million over a consecutive 30-day trading period. Cambrex reported a market capitalization of $74.8 million as of December 31, 2008. The company says that within the next 45... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|